Taiko Pharmaceutical Co Ltd
TSE:4574

Watchlist Manager
Taiko Pharmaceutical Co Ltd Logo
Taiko Pharmaceutical Co Ltd
TSE:4574
Watchlist
Price: 316 JPY 5.69% Market Closed
Market Cap: ¥16B

Wall Street
Price Targets

Price Targets Summary
Taiko Pharmaceutical Co Ltd

There are no price targets for Taiko Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Taiko Pharmaceutical Co Ltd Competitors:
Price Targets
WIPRO
Wipro Ltd
33% Upside

Revenue
Forecast

-13% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
-13% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 4 years the compound annual growth rate for Taiko Pharmaceutical Co Ltd's revenue is -13%. The projected CAGR for the next 2 years is 7%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Taiko Pharmaceutical Co Ltd

Net Income
Forecast

N/A
Past Growth
-38% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
-38% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

The compound annual growth rate of Taiko Pharmaceutical Co Ltd's net income for the next 2 years is -38%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Taiko Pharmaceutical Co Ltd's stock price target?
Not Available

Taiko Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Taiko Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
7%

For the last 4 years the compound annual growth rate for Taiko Pharmaceutical Co Ltd's revenue is -13%. The projected CAGR for the next 2 years is 7%.

What is Taiko Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-38%

The compound annual growth rate of Taiko Pharmaceutical Co Ltd's net income for the next 2 years is -38%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett